Stuart Pocock

258.4k total citations · 55 hit papers
582 papers, 143.9k citations indexed

About

Stuart Pocock is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Stuart Pocock has authored 582 papers receiving a total of 143.9k indexed citations (citations by other indexed papers that have themselves been cited), including 288 papers in Cardiology and Cardiovascular Medicine, 141 papers in Surgery and 116 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Stuart Pocock's work include Health Systems, Economic Evaluations, Quality of Life (104 papers), Heart Failure Treatment and Management (97 papers) and Acute Myocardial Infarction Research (96 papers). Stuart Pocock is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (104 papers), Heart Failure Treatment and Management (97 papers) and Acute Myocardial Infarction Research (96 papers). Stuart Pocock collaborates with scholars based in United Kingdom, United States and France. Stuart Pocock's co-authors include Douglas G. Altman, Matthias Egger, Erik von Elm, Peter C Gøtzsche, Jan P. Vandenbroucke, Ira Hill, John J.V. McMurray, Charles Poole, James J. Schlesselman and Cynthia D. Mulrow and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Stuart Pocock

562 papers receiving 140.3k citations

Hit Papers

The Strengthening the Reporting... 1975 2026 1992 2009 2007 2007 2007 2008 2014 5.0k 10.0k 15.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
    2007 18.0k citations Erik von Elm, Douglas G. Altman et al. profile →
  2. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
    2007 12.4k citations Erik von Elm, Douglas G. Altman et al. Annals of Internal Medicine profile →
  3. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    2007 11.6k citations Erik von Elm, Douglas G. Altman et al. The Lancet profile →
  4. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
    2008 10.1k citations Erik von Elm, Douglas G. Altman et al. Journal of Clinical Epidemiology profile →
  5. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
    2014 6.8k citations Erik von Elm, Douglas G. Altman et al. International Journal of Surgery profile →
  6. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
    2007 6.2k citations Erik von Elm, Douglas G. Altman et al. profile →
  7. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
    2007 6.1k citations Jan P. Vandenbroucke, Erik von Elm et al. profile →
  8. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
    2016 4.9k citations Stuart Pocock et al. New England Journal of Medicine profile →
  9. Clinical Trials: A Practical Approach.
    1984 2.3k citations Stuart Pocock et al. profile →
  10. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
    2007 2.1k citations Erik von Elm, Douglas G. Altman et al. profile →
  11. Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
    2010 2.0k citations Faı̈ez Zannad, John J.V. McMurray et al. New England Journal of Medicine profile →
  12. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
    2007 1.9k citations Jan P. Vandenbroucke, Erik von Elm et al. profile →
  13. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration
    2014 1.9k citations Jan P. Vandenbroucke, Erik von Elm et al. International Journal of Surgery profile →
  14. Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial
    1975 1.7k citations Stuart Pocock et al. profile →
  15. Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
    2009 1.4k citations Stefan D. Anker, Josep Comín Colet et al. New England Journal of Medicine profile →
  16. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement
    2007 1.3k citations Erik von Elm, Douglas G. Altman et al. profile →
  17. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation
    2016 1.3k citations Stuart Pocock et al. New England Journal of Medicine profile →
  18. Reporting of Noninferiority and Equivalence Randomized Trials
    2012 1.3k citations Stuart Pocock, Douglas G. Altman et al. profile →
  19. A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
    1998 1.2k citations Stuart Pocock et al. New England Journal of Medicine profile →
  20. Bivalirudin during Primary PCI in Acute Myocardial Infarction
    2008 1.2k citations Gregg W. Stone, Stuart Pocock et al. New England Journal of Medicine profile →
  21. Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents
    2007 1.2k citations Gregg W. Stone, Jeffrey W. Moses et al. New England Journal of Medicine profile →
  22. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies*
    2007 1.2k citations Erik von Elm, Douglas G. Altman et al. Bulletin of the World Health Organization profile →
  23. Group sequential methods in the design and analysis of clinical trials
    1977 1.1k citations Stuart Pocock profile →
  24. A Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting
    2004 1.0k citations Stuart Pocock et al. New England Journal of Medicine profile →
  25. Medical Research Council trial of treatment of hypertension in older adults: principal results.
    1992 1.0k citations Stuart Pocock et al. profile →
  26. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
    2009 1.0k citations Stuart Pocock, John J.V. McMurray et al. The Lancet profile →
  27. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies
    2012 846 citations Stuart Pocock, Cono Ariti et al. European Heart Journal profile →
  28. Reporting of Noninferiority and Equivalence Randomized Trials
    2006 843 citations Douglas G. Altman, Stuart Pocock et al. profile →
  29. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
    2020 831 citations Faı̈ez Zannad, João Pedro Ferreira et al. The Lancet profile →
  30. Subgroup analysis and other (mis)uses of baseline data in clinical trials
    2000 798 citations Stuart Pocock et al. The Lancet profile →
  31. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials
    2000 794 citations Stuart Pocock et al. The Lancet profile →
  32. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practiceand problems
    2002 775 citations Stuart Pocock et al. profile →
  33. Predictors of mortality and morbidity in patients with chronic heart failure
    2005 757 citations Stuart Pocock, Duolao Wang et al. European Heart Journal profile →
  34. Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure
    2007 752 citations Stuart Pocock, John J.V. McMurray et al. profile →
  35. Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
    2006 733 citations Marc A. Pfeffer, Karl Swedberg et al. Circulation profile →
  36. Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure
    2007 645 citations Milton Packer, Stuart Pocock et al. profile →
  37. Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients
    2005 609 citations Scott D. Solomon, Hicham Skali et al. Circulation profile →
  38. Strategy for intention to treat analysis in randomised trials with missing outcome data
    2011 607 citations Stuart Pocock et al. profile →
  39. Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis
    2007 561 citations Stuart Pocock, John J.V. McMurray et al. New England Journal of Medicine profile →
  40. Statistical guidelines for contributors to medical journals.
    1983 498 citations S M Gore, Stuart Pocock et al. BMJ profile →
  41. Comparison of Propensity Score Methods and Covariate Adjustment
    2017 481 citations Samantha Sartori, Roxana Mehran et al. profile →
  42. Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure
    2007 457 citations Scott D. Solomon, Joanna Dobson et al. Circulation profile →
  43. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns.
    1981 455 citations A. G. Shaper, Stuart Pocock et al. profile →
  44. A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes
    2010 444 citations Roxana Mehran, Stuart Pocock et al. profile →
  45. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials
    2015 372 citations Joanna Dobson, Stuart Pocock et al. The Lancet profile →
  46. BMI and risk of dementia in two million people over two decades: a retrospective cohort study
    2015 339 citations Stuart Pocock et al. profile →
  47. Prevalence, Impact, and Predictive Value of Detecting Subclinical Coronary and Carotid Atherosclerosis in Asymptomatic Adults
    2015 297 citations Roxana Mehran, Samantha Sartori et al. profile →
  48. Effects of Ferric Carboxymaltose on Hospitalisations and Mortality Rates in Iron-Deficient Heart Failure Patients: An Individual Patient data Meta-Analysis
    2017 291 citations Stefan D. Anker, Bridget‐Anne Kirwan et al. European Journal of Heart Failure profile →
  49. Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction
    2020 266 citations Milton Packer, Stefan D. Anker et al. Circulation profile →
  50. Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review
    2017 263 citations Stuart Pocock et al. profile →
  51. Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status
    2020 243 citations Stefan D. Anker, Javed Butler et al. Circulation profile →
  52. Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial
    2021 226 citations Milton Packer, Javed Butler et al. Circulation profile →
  53. Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention
    2020 204 citations Roxana Mehran, Stuart Pocock et al. profile →
  54. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
    2022 168 citations Stuart Pocock, Martin Fahy et al. The Lancet profile →
  55. Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
    2021 159 citations Javed Butler, Milton Packer et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart Pocock United Kingdom 117 37.0k 32.9k 16.9k 16.7k 16.1k 582 143.9k
Julian P. T. Higgins United Kingdom 118 18.8k 0.5× 34.4k 1.0× 23.9k 1.4× 23.0k 1.4× 11.1k 0.7× 471 205.3k
Ralph B. D’Agostino United States 196 59.4k 1.6× 28.8k 0.9× 25.8k 1.5× 16.0k 1.0× 32.6k 2.0× 1.4k 175.5k
Peter C Gøtzsche Denmark 74 20.1k 0.5× 41.2k 1.3× 25.8k 1.5× 23.5k 1.4× 8.8k 0.5× 295 204.5k
George Davey Smith United Kingdom 182 19.6k 0.5× 23.5k 0.7× 26.8k 1.6× 14.4k 0.9× 15.8k 1.0× 2.0k 218.3k
Matthias Egger Switzerland 134 18.7k 0.5× 37.1k 1.1× 32.9k 1.9× 20.4k 1.2× 9.4k 0.6× 780 212.8k
Alessandro Liberati Italy 41 14.8k 0.4× 34.5k 1.0× 22.3k 1.3× 19.2k 1.1× 7.5k 0.5× 87 193.0k
Gordon Guyatt Canada 192 20.0k 0.5× 33.7k 1.0× 23.0k 1.4× 29.7k 1.8× 7.3k 0.5× 1.4k 174.1k
Salim Yusuf Canada 181 103.5k 2.8× 28.9k 0.9× 15.1k 0.9× 14.0k 0.8× 24.4k 1.5× 1.3k 157.0k
Peter W.F. Wilson United States 156 35.2k 1.0× 31.0k 0.9× 14.4k 0.9× 8.1k 0.5× 29.9k 1.9× 646 110.5k
Josef Coresh United States 133 30.8k 0.8× 16.1k 0.5× 14.4k 0.9× 16.2k 1.0× 16.9k 1.0× 952 116.0k

Countries citing papers authored by Stuart Pocock

Since Specialization
Citations

This map shows the geographic impact of Stuart Pocock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Pocock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Pocock more than expected).

Fields of papers citing papers by Stuart Pocock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Pocock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Pocock. The network helps show where Stuart Pocock may publish in the future.

Co-authorship network of co-authors of Stuart Pocock

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Pocock. A scholar is included among the top collaborators of Stuart Pocock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Pocock. Stuart Pocock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giacoppo, Daniele, Felice Gragnano, Hirotoshi Watanabe, et al.. (2025). P2Y12inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials. BMJ. 389. e082561–e082561. 10 indexed citations
2.
Oliva, Angelo, Birgit Vogel, Samantha Sartori, et al.. (2025). Association of neutrophil-to-lymphocyte ratio with clinical outcomes after percutaneous coronary intervention. European Journal of Preventive Cardiology. 33(5). 669–678.
3.
Kotanidis, Christos P., Bjørn Bendz, Erlend Sturle Berg, et al.. (2024). Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis. European Heart Journal. 45(23). 2052–2062. 30 indexed citations
4.
Ferreira, João Pedro, Milton Packer, Naveed Sattar, et al.. (2024). Insulin-Like Growth Factor Binding Protein-7 Concentrations in Chronic Heart Failure: Results from the EMPEROR Programme. European Journal of Heart Failure. 26(4). 806–816. 5 indexed citations
5.
Sharma, Abhinav, João Pedro Ferreira, Faı̈ez Zannad, et al.. (2023). Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from the EMPEROR-Preserved Trial. European Journal of Heart Failure. 25(8). 1337–1348. 33 indexed citations
6.
Zannad, Faı̈ez, Filippo Crea, John F. Keaney, et al.. (2023). Rapid, accurate publication and dissemination of clinical trial results: benefits and challenges. European Heart Journal. 44(40). 4220–4229. 6 indexed citations
7.
Monzo, Luca, Nicolas Girerd, Kévin Duarte, et al.. (2023). Time to Clinical Benefit of Eplerenone Among Patients with Heart Failure and Reduced Ejection Fraction: A Subgroups Analysis from the EMPHASIS-HF Trial. European Journal of Heart Failure. 25(8). 1444–1449. 8 indexed citations
8.
Scutt, Polly, D. Blackburn, Kailash Krishnan, et al.. (2015). Baseline characteristics, analysis plan and report on feasibility for the Prevention Of Decline in Cognition After Stroke Trial (PODCAST). Trials. 16(1). 509–509. 5 indexed citations
9.
Elm, Erik von, Douglas G. Altman, Matthias Egger, et al.. (2014). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. International Journal of Surgery. 12(12). 1495–1499. 6752 indexed citations breakdown →
10.
Pocock, Stuart, Cono Ariti, John J.V. McMurray, et al.. (2012). Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. European Heart Journal. 34(19). 1404–1413. 846 indexed citations breakdown →
11.
Pocock, Stuart, Roxana Mehran, Tim Clayton, et al.. (2009). Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic Complications. Circulation. 121(1). 43–51. 87 indexed citations
12.
Anker, Stefan D., Josep Comín Colet, Gerasimos Filippatos, et al.. (2009). Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. New England Journal of Medicine. 361(25). 2436–2448. 1401 indexed citations breakdown →
13.
Hawkins, Nathaniel M., Duolao Wang, John J.V. McMurray, et al.. (2007). Prevalence and Prognostic Impact of Bundle Branch Block in Patients with Heart Failure: Evidence from the CHARM Programme. European Journal of Heart Failure. 9(5). 510–517. 45 indexed citations
14.
Elm, Erik von, Douglas G. Altman, Matthias Egger, et al.. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. The Lancet. 370(9596). 1453–1457. 11648 indexed citations breakdown →
15.
Elm, Erik von, Douglas G. Altman, Matthias Egger, et al.. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies */Declaration De l'Initiative STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) : Recommandations Pour L'elaboration Des Rapports D'etudes Observationnelles/ Declaracion De la Iniciativa STOBE. Bulletin of the World Health Organization. 85(11). 867. 7 indexed citations
16.
Elm, Erik von, Douglas G. Altman, Matthias Egger, et al.. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Annals of Internal Medicine. 147(8). 573–577. 12444 indexed citations breakdown →
17.
Solomon, Scott D., Joanna Dobson, Stuart Pocock, et al.. (2007). Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure. Circulation. 116(13). 1482–1487. 457 indexed citations breakdown →
18.
Chang, Bei‐Hung & Stuart Pocock. (2000). Analyzing data with clumping at zero. Journal of Clinical Epidemiology. 53(10). 1036–1043. 37 indexed citations
19.
Pocock, Stuart, A. G. Shaper, Andrew Phillips, Mary Walker, & T. P. Whitehead. (1986). High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.. BMJ. 292(6519). 515–519. 102 indexed citations
20.
Langlands, A.O., Stuart Pocock, G.R. Kerr, & S M Gore. (1979). Long-term survival of patients with breast cancer: a study of the curability of the disease.. BMJ. 2(6200). 1247–1251. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julian P. T. Higgins Breakdown of academic impact, for papers by Ralph B. D’Agostino Breakdown of academic impact, for papers by Peter C Gøtzsche Breakdown of academic impact, for papers by George Davey Smith Breakdown of academic impact, for papers by Matthias Egger Breakdown of academic impact, for papers by Alessandro Liberati Breakdown of academic impact, for papers by Gordon Guyatt Breakdown of academic impact, for papers by Salim Yusuf Breakdown of academic impact, for papers by Peter W.F. Wilson Breakdown of academic impact, for papers by Josef Coresh
Rankless by CCL
2026